Research graph
References from Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/path.1570
10.1002/path.1570 · External reference
Risk factors for SARS among persons without known contact with SARS Patients, Beijing, China
2004 · External reference
10.1001/jama.2020.2565
10.1001/jama.2020.2565 · External reference
10.1016/j.csbj.2020.12.033 · Admitted local publication
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)
2020 · External reference
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)
2020 · External reference
10.1016/j.csbj.2021.04.014
10.1016/j.csbj.2021.04.014 · External reference
The COVID-19 epidemic analysis and diagnosis using deep learning: a systematic literature review and future directions
10.1016/j.compbiomed.2021.105141 · 2022 · External reference
A privacy-aware method for COVID-19 detection in chest CT images using lightweight deep conventional neural network and blockchain
10.1016/j.compbiomed.2022.105461 · 2022 · External reference
Machine learning applications for COVID-19 outbreak management
10.1007/s00521-022-07424-w · 2022 · External reference
A privacy-aware method for COVID-19 detection in chest CT images using lightweight deep conventional neural network and blockchain
10.1016/j.compbiomed.2022.105461 · 2022 · External reference
10.1038/s41467-021-25040-5
10.1038/s41467-021-25040-5 · External reference
Delineating COVID-19 immunological features using single-cell RNA sequencing
2022 · External reference
10.1038/s41587-020-0602-4
10.1038/s41587-020-0602-4 · External reference
Forodesine and riboprine exhibit strong anti-SARS-CoV-2 Repurposing Potential: in silico and in vitro studies
10.1021/acsbiomedchemau.2c00039 · 2022 · External reference
The informative nature of the disappeared SARS-CoV-2 genomic sequences: a mini-review with perspectives
2022 · External reference
10.1016/j.crphar.2021.100055
10.1016/j.crphar.2021.100055 · External reference
10.1039/d0nj03708g
10.1039/d0nj03708g · External reference
Novel investigational Anti-SARS-CoV-2 agent ensitrelvir “S-217622″: a very promising potential universal broad-spectrum antiviral at the therapeutic frontline of coronavirus species
10.1021/acsomega.2c03881 · 2023 · External reference
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: a repurposing research study
10.1007/s00044-022-02970-3 · 2023 · External reference
10.1038/nrg2934
10.1038/nrg2934 · External reference
RNA sequencing and analysis
10.1101/pdb.top084970 · 2015 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
Open access Volume 14(4) hypothesis biomarker identification from RNA-Seq data using a robust statistical approach
10.6026/97320630014153 · 2018 · External reference
10.1038/nrg2484
10.1038/nrg2484 · External reference
Sequencing
2008 · External reference
10.1016/j.ygeno.2008.07.001
10.1016/j.ygeno.2008.07.001 · External reference
RNA sequencing: advances, challenges and opportunities
2010 · External reference
RNA sequencing and analysis
10.1101/pdb.top084970 · 2015 · External reference
Are antisense long non-coding RNA related to COVID-19?
10.3390/biomedicines10112770 · 2022 · External reference
10.3390/v15051177
10.3390/v15051177 · External reference
10.3390/ncrna7030054
10.3390/ncrna7030054 · External reference
Mapping CircRNA–miRNA–mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection
10.1371/journal.pone.0283589 · 2023 · External reference
10.3390/ncrna7010009
10.3390/ncrna7010009 · External reference
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19
10.1124/jpet.122.001209 · 2022 · External reference
Role of the MicroRNAs in the pathogenic mechanism of painful symptoms in long COVID: systematic review
10.3390/ijms24043574 · 2023 · External reference
10.3390/biomedicines11051348
10.3390/biomedicines11051348 · External reference
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
10.1080/15384101.2020.1867792 · 2021 · External reference
Pharmacological mechanism of NRICM101 for COVID-19 treatments by combined network pharmacology and pharmacodynamics
2022 · External reference
Biomarker identification from RNA-Seq data using a robust statistical approach
10.6026/97320630014153 · 2018 · External reference
Disease biomarker query from RNA-Seq data
2014 · External reference
10.1186/s13059-016-0881-8
10.1186/s13059-016-0881-8 · External reference
An evaluation of RNA-seq differential analysis methods
10.1371/journal.pone.0264246 · 2022 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1186/gb-2010-11-10-r106
10.1186/gb-2010-11-10-r106 · External reference
10.1093/bioinformatics/btu684
10.1093/bioinformatics/btu684 · External reference
The impact of quality control in RNA-seq experiments
10.1088/1742-6596/705/1/012003 · 2016 · External reference
10.1093/bioinformatics/btl117
10.1093/bioinformatics/btl117 · External reference
10.1186/gb-2014-15-2-r29
10.1186/gb-2014-15-2-r29 · External reference
PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
2022 · External reference
SARS-CoV-2 Switches ‘on’ MAPK and NFκB signaling via the reduction of nuclear DUSP1 and DUSP5 expression
10.3389/fphar.2021.631879 · 2021 · External reference
10.1080/10463356.2022.2055427
10.1080/10463356.2022.2055427 · External reference
Remote home monitoring of patients with cancer during the COVID-19 pandemic
10.1080/10463356.2022.2055427 · 2022 · External reference
10.1056/nejmcp2009249
10.1056/nejmcp2009249 · External reference
10.1111/all.14657
10.1111/all.14657 · External reference
Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome
10.1086/381535 · 2004 · External reference
10.1016/j.cbi.2021.109480
10.1016/j.cbi.2021.109480 · External reference
Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication
10.1021/acsomega.1c05998 · 2022 · External reference
Potent dual polymerase/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 omicron virus: a promising in silico/in vitro repositioning research study
2023 · External reference
Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease
10.1021/acsomega.1c07095 · 2022 · External reference
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence
10.1186/1471-2407-10-108 · 2010 · External reference
10.1002/ajmg.a.62352
10.1002/ajmg.a.62352 · External reference
Germline variant in REXO2 is a novel candidate gene in familial pheochromocytoma
2020 · External reference
10.1016/s0092-8674(03)00045-x
10.1016/s0092-8674(03)00045-x · External reference
Identification of potential biomarkers and inhibitors for SARS-CoV-2 infection
2020 · External reference
APOBEC3A regulates transcription from interferon-stimulated response elements
10.1073/pnas.2011665119 · 2022 · External reference
Association between the HLA genotype and the severity of COVID-19 infection among South Asians
10.1002/jmv.27003 · 2021 · External reference
The influence of HLA genotype on the severity of COVID-19 infection
10.1111/tan.14284 · 2021 · External reference
Targeting TNF-α for COVID-19: recent advanced and controversies
2022 · External reference
Activating killer-cell immunoglobulin-like receptors are associated with the severity of coronavirus disease 2019
10.1093/infdis/jiab228 · 2021 · External reference
10.1016/j.compbiomed.2022.105684
10.1016/j.compbiomed.2022.105684 · External reference
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
10.1186/s12859-020-03872-0 · 2020 · External reference
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets
10.1093/bib/bbab403 · 2022 · External reference
10.1261/rna.053959.115
10.1261/rna.053959.115 · External reference
